Advicenne Secures Unlimited UK Renewal for Rare Kidney Drug Sibnayal, Boosting Nephrology Market Share
Advicenne’s unlimited UK renewal of Sibnayal for rare kidney disease shows its growing leadership in pediatric nephrology and boosts market reach.
2 minutes to read